This review examines MEDVi QUAD, a compounded sublingual ED treatment combining four active ingredients. It separates marketing claims from evidence, covers the formula changes, regulatory issues, and real customer experiences to help readers decide whether it’s worth considering.
MEDVi QUAD Review: An Honest Look at the 4-in-1 ED Formula
If you’ve been researching MEDVi QUAD, you’ve probably noticed something frustrating: every review seems to describe a different product.
That’s not your imagination. MEDVi has changed the QUAD formula at least twice. Reviews from early 2026 describe one combination. Reviews from mid-2026 describe another. The current version may be different again.
This article cuts through the confusion. We’ll explain what QUAD is now, what the evidence says about each ingredient, what the regulatory issues are, and what real customers report. No fabricated ratings. No affiliate hype. Just what’s verifiable.
What MEDVi QUAD Is (and Why the Formula Keeps Changing)
MEDVi QUAD is a compounded prescription sublingual liquid marketed for erectile dysfunction. You complete an online intake, a licensed clinician reviews it, and if approved, a compounding pharmacy prepares and ships the medication.
The company operates through three separate entities: MEDVi, LLC (the platform), CareGLP Affiliated P.C.s and OpenLoop Health (the prescribing medical group), and Belmar Pharma Solutions (the compounding pharmacy).
Here’s the formula problem in plain terms:
MEDVi reportedly told one publication directly that PT-141 and L-Citrulline replaced Vardenafil and Apomorphine. If you’re reading a review written before July 2026, it may describe a product that no longer exists.
Before you pay, get the exact ingredient list, strengths, and pharmacy name in writing. Do not assume any “QUAD” review describes the same prescription you’d receive.
The Four Current Ingredients: What Each Actually Does
The current formula combines two well-established ED drugs with two less-proven additions.
Sildenafil (Viagra). The most studied ED medication. Works by relaxing smooth muscle and increasing blood flow to penile tissue. Onset is typically 30–60 minutes orally, potentially faster sublingually. Extensive human trial data.
Tadalafil (Cialis). Also a PDE5 inhibitor, but with a longer half-life — effects can last up to 36 hours. This allows more spontaneous timing without rigid planning. Also well-studied.
PT-141 (Bremelanotide). This is where things get murky. PT-141 is FDA-approved for hypoactive sexual desire disorder in premenopausal women, not for erectile dysfunction in men. It works on dopamine pathways in the brain rather than blood flow. Evidence for male ED is limited and mostly off-label.
L-Citrulline. An amino acid that converts to L-arginine, which can support nitric oxide production and mild vasodilation. Some small studies suggest modest benefits for mild ED. It is not a prescription-strength intervention and is widely available as a supplement.
The honest summary: Two ingredients have strong evidence. Two have limited or indirect evidence for male ED. The combination has never been tested in a clinical trial.
The Regulatory Problem Most Reviews Skip
This is the part that matters and almost never gets mentioned.
MEDVi QUAD is a compounded medication. Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality as finished products before reaching patients.
That’s not automatically bad — compounding serves legitimate medical needs. But there are specific concerns here:
- Stacking two PDE5 inhibitors (sildenafil and tadalafil) is pharmacologically unusual. Both act on the same pathway and both lower blood pressure. A prescriber should explain why two drugs from the same class are needed.
- Both sildenafil and tadalafil must not be used with nitrate medications (nitroglycerin, isosorbide). The combination can cause a dangerous blood pressure drop.
- MEDVi has already received an FDA warning letter — for misbranding compounded GLP-1 drugs, not ED products, but it signals a pattern of regulatory friction.
If you take heart medication, carry nitroglycerin, have fainting episodes, or have been told sexual activity may be unsafe for your heart, disclose that before treatment. Do not leave it for a checkout form to guess.
What Real Customers Say (and What Affiliate Sites Won’t Tell You)
This is where the picture splits sharply.
Affiliate review sites describe 4.5–4.6/5 ratings, LegitScript certification, and thousands of satisfied users. These sites earn commissions when you enroll.
Trustpilot tells a different story. The rating is 2.8/5, with recurring complaints:
- “Worthless product. Has absolutely no affect on anything! Scam product.”
- “I answered all the questions and received an email saying I qualified… I paid $119. Then I get an email saying I don’t qualify… Won’t refund my money even though they have a money back guarantee.”
- “Beware, they charge $199/month for subscription and won’t refund without 72 hours before renewal date. They sell you defective product, won’t take return and bill you for more whether you want it or not.”
- “While I have to say the product worked well I’m less impressed with the automated subscription I unwittingly signed up for. I was subsequently charged for two orders and only received one before I was finally able to cancel.”
One customer reported canceling on March 31st, being charged again on April 6th, and being told to “contact my bank” because the company couldn’t reverse the charge.
The pattern: Some users report the product works. Many report billing and cancellation problems regardless of whether the medication helped. The business model appears to rely on subscriptions that are difficult to exit.
Pricing and Refund Terms
Pricing varies by offer and has changed over time. Sources cite figures ranging from $114/month** (discounted) to **$119/month to $199/month at full retail.
Critical points:
- It’s a subscription. Multiple customers report being charged after attempting to cancel.
- Cancellation deadlines matter. One complaint references a 72-hour window before renewal. Miss it, and you’re charged again.
- The “no-approval policy” means you’re not charged if the clinician declines your prescription — but complaints suggest refunds are difficult even when the product doesn’t work.
- Money-back guarantees appear in marketing but customers report they’re not honored in practice.
Real Risks and Side Effects
Beyond the standard injectable risks (this is sublingual, so no needles, but still):
- Blood pressure drops. Stacking PDE5 inhibitors amplifies this risk.
- Nitrate interaction. Potentially dangerous. Disclose all heart medications.
- Nausea. A known side effect of apomorphine in older formulas and PT-141 in the current one.
- Flushing, nasal stuffiness, headache. Common with PDE5 inhibitors.
- Unknown long-term effects. The combination has never been studied long-term.
- Quality variability. Compounded products are not held to the same consistency standards as approved drugs.
Who This Probably Isn’t For
Be honest with yourself here. MEDVi QUAD is likely a poor fit if you:
- Take nitrates, riociguat, or certain alpha-blockers
- Have uncontrolled blood pressure or heart conditions
- Want FDA-approved, evidence-backed treatment (Viagra, Cialis, and Levitra all have far stronger human data as standalone products)
- Are uncomfortable with subscription models and aggressive billing practices
- Expect a “guarantee” to be honored without a fight
Who It Might Suit
Possibly suitable if you:
- Have tried single-ingredient ED medications and found results inconsistent
- Are medically cleared by a clinician who reviews your full history
- Understand this is a compounded, non-FDA-approved combination
- Are willing to monitor your subscription carefully and cancel well before deadlines
- Accept that two of the four ingredients have limited evidence for male ED
The Verdict
MEDVi QUAD is a compounded, non-FDA-approved ED treatment with a formula that keeps changing and a business model that generates consistent billing complaints.
Two of its ingredients have strong evidence. Two do not. The combination has never been clinically tested. The company has an FDA warning letter on record for a different product line. Trustpilot reviews are notably poor, especially regarding billing and cancellation.
If you’re considering it, the best next step isn’t clicking a buy button. It’s talking to your own physician about whether combination ED therapy makes sense for you — and whether FDA-approved options would serve you better with far less financial and regulatory uncertainty.
FAQ
Is MEDVi QUAD FDA-approved?
No. It’s a compounded medication. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality as finished products.
What’s actually in MEDVi QUAD?
The current formula (as of July 2026) is sildenafil, tadalafil, PT-141, and L-Citrulline. Older versions contained vardenafil and apomorphine. Verify the exact formula before paying.
Does it work?
Some users report positive results. Others report no effect. The combination has never been clinically tested, and two ingredients have limited evidence for male ED.
Can I cancel my subscription?
Customers report difficulty canceling and being charged after cancellation attempts. If you enroll, monitor your subscription carefully and cancel well before any renewal deadline.
Is it safe to take two PDE5 inhibitors together?
Both sildenafil and tadalafil lower blood pressure. Combining them amplifies this risk. A prescriber should explain why two drugs from the same class are needed.
Is there a money-back guarantee?
Marketing materials reference one, but Trustpilot complaints suggest it’s difficult to obtain.
